CLINICAL STUDY
Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization
Karl-Christian Koch, MD*,
Juergen vom Dahl, MD, FESC*,
Monika Wenderdel*,
Bernd Nowak, MD ,
Wolfgang M. Schaefer, PhD,
Alexander Sasse, MD*,
Christoph Stellbrink, MD*,
Udalrich Buell, MD and
Peter Hanrath, MD, FACC, FESC*
* Medizinische Klinik I (Department of Cardiology), Aachen, Germany
Department of Nuclear Medicine, University Hospital, Aachen, Germany
Manuscript received October 23, 2000;
revised manuscript received March 7, 2001,
accepted March 26, 2001.
Reprint requests and correspondence: Dr. Jürgen vom Dahl, Medizinische Klinik I, Universitätsklinikum der RWTH Aachen, Pauwelstrasse 30, D-52057 Aachen, Germany
jvomdahl{at}post.klinikum.rwth-aachen.de
OBJECTIVES
The objective of this study was to compare electroanatomic mapping for the assessment of myocardial viability with nuclear metabolic imaging using positron emission computed tomography (PET) and with data on functional recovery after successful myocardial revascularization.
BACKGROUND
Animal experiments and first clinical studies suggested that electroanatomic endocardial mapping identifies the presence and absence of myocardial viability.
METHODS
Forty-six patients with prior ( 2 weeks) myocardial infarction underwent fluorine-18 fluorodeoxyglucose (FDG) PET and Tc-99m sestamibi single-photon emission computed tomography (SPECT) before mapping and percutaneous coronary revascularization. The left ventricular endocardium was mapped and divided into 12 regions, which were assigned to corresponding nuclear regions. Functional recovery using the centerline method was assessed in 25 patients with a follow-up angiography.
RESULTS
Regional unipolar electrogram amplitude was 11.0 mV ± 3.6 mV in regions with normal perfusion, 9.0 mV ± 2.8 mV in regions with reduced perfusion and preserved FDG-uptake and 6.5 mV ± 2.6 mV in scar regions (p < 0.001 for all comparisons). At a threshold amplitude of 7.5 mV, the sensitivity and specificity for detecting viable (by PET/SPECT) myocardium were 77% and 75%, respectively. In infarct areas with electrogram amplitudes >7.5 mV, improvement of regional wall motion (RWM) from –2.4 SD/chord ± 1.0 SD/chord to –1.5 SD/chord ± 1.1 SD/chord (p < 0.01) was observed, whereas, in infarct areas with amplitudes <7.5 mV, RWM remained unchanged at follow-up (–2.3 SD/chord ± 0.7 SD/chord to –2.4 SD/chord ± 0.7 SD/chord).
CONCLUSIONS
These data suggest that the regional unipolar electrogram amplitude is a marker for myocardial viability and that electroanatomic mapping can be used for viability assessment in the catheterization laboratory.
|
Abbreviations and Acronyms
| | AUC | = area under the curve | | CI | = confidence interval | | FDG | = F-18 fluorodeoxyglucose | | LAD | = left anterior descending artery | | LCX | = left circumflex artery | | LV | = left ventricle or left ventricular | | MI | = myocardial infarction | | PET | = positron emission computed tomography | | PTCA | = percutaneous transluminal coronary angioplasty | | RCA | = right coronary artery | | ROC | = receiver operator curve | | RWM | = regional wall motion | | SPECT | = single photon emission computed tomography |
|
This article has been cited by other articles:
|
|
|
|
 
E. C. Perin and G. V. Silva
Stem cell therapy in end-stage ischaemic heart failure: a catheter-based therapeutic strategy targeting myocardial viability
Eur. Heart J. Suppl.,
December 1, 2006;
8(suppl_H):
H46 - H51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F L Schinkel, J. J Bax, and D. Poldermans
Clinical assessment of myocardial hibernation
Heart,
January 1, 2005;
91(1):
111 - 117.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Thiagalingam, E. M. Wallace, C. R. Campbell, A. C. Boyd, V. E. Eipper, K. Byth, D. L. Ross, and P. Kovoor
Value of Noncontact Mapping for Identifying Left Ventricular Scar in an Ovine Model
Circulation,
November 16, 2004;
110(20):
3175 - 3180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Samady, C. J. Choi, M. Ragosta, E. R. Powers, G. A. Beller, and C. M. Kramer
Electromechanical Mapping Identifies Improvement in Function and Retention of Contractile Reserve After Revascularization in Ischemic Cardiomyopathy
Circulation,
October 19, 2004;
110(16):
2410 - 2416.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Graf, M. Gyongyosi, A. Khorsand, S. G. Nekolla, C. Pirich, K. Kletter, R. Dudczak, D. Glogar, G. Porenta, and H. Sochor
Electromechanical Properties of Perfusion/Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET
J. Nucl. Med.,
October 1, 2004;
45(10):
1611 - 1618.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J.,
May 2, 2004;
25(10):
815 - 836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wiggers, H. E. Botker, P. Sogaard, A. Kaltoft, F. Hermansen, W. Y. Kim, L. Krusell, and L. Thuesen
Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy
J. Am. Coll. Cardiol.,
March 5, 2003;
41(5):
843 - 848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kornowski
Left ventricular electromechanical mapping for determination of myocardial function and viability
J. Am. Coll. Cardiol.,
September 18, 2002;
40(6):
1075 - 1078.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Perin, G. V. Silva, R. Sarmento-Leite, A. L.S. Sousa, M. Howell, R. Muthupillai, B. Lambert, W. K. Vaughn, and S. D. Flamm
Assessing Myocardial Viability and Infarct Transmurality With Left Ventricular Electromechanical Mapping in Patients With Stable Coronary Artery Disease: Validation by Delayed-Enhancement Magnetic Resonance Imaging
Circulation,
August 20, 2002;
106(8):
957 - 961.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
